Fig. 1From: Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosisBox plots of changes in body weight and body mass index following Elexacaftor/Tezacaftor/Ivacaftor therapy in patients with cystic fibrosis showing heterogeneity in treatment responseBack to article page